Huntsman (NYSE:HUN – Free Report) had its price objective reduced by The Goldman Sachs Group from $19.00 to $13.50 in a research note released on Tuesday morning,Benzinga reports. They currently have a sell rating on the basic materials company’s stock.
A number of other equities research analysts have also issued reports on the stock. Morgan Stanley cut their price objective on shares of Huntsman from $20.00 to $13.50 and set an “equal weight” rating for the company in a report on Monday. Bank of America downgraded shares of Huntsman from a “buy” rating to a “neutral” rating and reduced their price target for the company from $22.00 to $15.00 in a report on Tuesday, April 15th. Alembic Global Advisors downgraded shares of Huntsman from an “overweight” rating to a “neutral” rating in a report on Wednesday, January 15th. StockNews.com downgraded Huntsman from a “hold” rating to a “sell” rating in a research report on Monday. Finally, Mizuho cut their price target on Huntsman from $23.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $15.00.
View Our Latest Analysis on Huntsman
Huntsman Stock Down 1.8 %
Huntsman (NYSE:HUN – Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The basic materials company reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). Huntsman had a negative return on equity of 0.39% and a negative net margin of 3.13%. The business had revenue of $1.41 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same period in the previous year, the business earned ($0.06) earnings per share. The business’s revenue was down 4.1% on a year-over-year basis. Sell-side analysts expect that Huntsman will post 0.32 EPS for the current fiscal year.
Huntsman Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Friday, June 13th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 8.77%. The ex-dividend date of this dividend is Friday, June 13th. Huntsman’s payout ratio is -109.89%.
Institutional Trading of Huntsman
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Hexagon Capital Partners LLC increased its position in Huntsman by 177.9% during the first quarter. Hexagon Capital Partners LLC now owns 2,179 shares of the basic materials company’s stock valued at $34,000 after acquiring an additional 1,395 shares during the last quarter. R Squared Ltd bought a new position in Huntsman during the 4th quarter valued at about $40,000. Quadrant Capital Group LLC raised its position in Huntsman by 74.9% in the 4th quarter. Quadrant Capital Group LLC now owns 2,232 shares of the basic materials company’s stock worth $40,000 after purchasing an additional 956 shares during the period. Aster Capital Management DIFC Ltd bought a new stake in Huntsman in the fourth quarter worth about $60,000. Finally, Versant Capital Management Inc grew its stake in shares of Huntsman by 2,388.4% during the first quarter. Versant Capital Management Inc now owns 4,081 shares of the basic materials company’s stock valued at $64,000 after buying an additional 3,917 shares during the last quarter. Hedge funds and other institutional investors own 84.81% of the company’s stock.
Huntsman Company Profile
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Further Reading
- Five stocks we like better than Huntsman
- CD Calculator: Certificate of Deposit Calculator
- 3 Mid-Cap Medical Stocks Outperforming the Market
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- The Top-Ranked Insider Buys From April by Market Cap
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.